Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.
作者信息
Mogensen Signe Sloth, Schmiegelow Kjeld, Grell Kathrine, Albertsen Birgitte Klug, Wehner Peder Skov, Kampmann Peter, Frandsen Thomas Leth
机构信息
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.
Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Denmark.
出版信息
Haematologica. 2017 May;102(5):e175-e178. doi: 10.3324/haematol.2016.160507. Epub 2017 Feb 16.
Abstract
摘要
相似文献
1
Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.
Haematologica. 2017 May;102(5):e175-e178. doi: 10.3324/haematol.2016.160507. Epub 2017 Feb 16.
2
The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Pediatr Blood Cancer. 2015 Oct;62(10):1851-4. doi: 10.1002/pbc.25553. Epub 2015 Apr 29.
3
Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP).
Blood Cancer J. 2018 Nov 15;8(12):115. doi: 10.1038/s41408-018-0150-z.
4
Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.
Blood. 2019 Sep 19;134(12):983-986. doi: 10.1182/blood.2019000006. Epub 2019 Aug 13.
5
Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
Pediatr Blood Cancer. 2007 Oct 15;49(5):764. doi: 10.1002/pbc.21141.
6
Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Pediatr Blood Cancer. 2018 Oct;65(10):e27300. doi: 10.1002/pbc.27300. Epub 2018 Jun 26.
7
High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
Leukemia. 2008 Feb;22(2):308-12. doi: 10.1038/sj.leu.2405032. Epub 2007 Nov 8.
8
Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
Int J Hematol. 2015 Jul;102(1):41-7. doi: 10.1007/s12185-015-1790-4. Epub 2015 Apr 4.
9
Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.
Haematologica. 2014 Mar;99(3):430-6. doi: 10.3324/haematol.2013.095562.
10
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
J Clin Oncol. 2000 Sep 15;18(18):3262-72. doi: 10.1200/JCO.2000.18.18.3262.
引用本文的文献
1
Acute therapy-related toxicities in pediatric acute lymphoblastic leukemia.
Haematologica. 2025 Sep 1;110(9):1923-1933. doi: 10.3324/haematol.2024.285702. Epub 2025 Mar 6.
2
Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial.
Haematologica. 2025 Aug 1;110(8):1723-1735. doi: 10.3324/haematol.2024.286043. Epub 2025 Feb 20.
3
Bone health in childhood cancer survivors, is there really a problem? Pitfalls of assessment, calculating risk, and suggested surveillance and management for osteonecrosis and low and very low bone mineral density.
Endocr Connect. 2024 Nov 21;13(12). doi: 10.1530/EC-24-0487. Print 2024 Dec 1.
4
Phytochemical components analysis and hypolipidemic effect on hyperlipidemia mice of the aerial parts from .
Front Nutr. 2024 Jul 25;11:1422857. doi: 10.3389/fnut.2024.1422857. eCollection 2024.
5
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding.
Expert Opin Drug Metab Toxicol. 2023 Jan-Jun;19(6):357-366. doi: 10.1080/17425255.2023.2233412.
6
[Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia].
Orthopadie (Heidelb). 2022 Oct;51(10):792-799. doi: 10.1007/s00132-022-04301-1. Epub 2022 Sep 7.
7
The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.
Mediators Inflamm. 2022 Jun 17;2022:3101900. doi: 10.1155/2022/3101900. eCollection 2022.
8
Polysaccharides from Medicine and Food Homology Materials: A Review on Their Extraction, Purification, Structure, and Biological Activities.
Molecules. 2022 May 17;27(10):3215. doi: 10.3390/molecules27103215.
9
Osteonecrosis of the Femoral Head.
J Am Acad Orthop Surg Glob Res Rev. 2022 May 1;6(5):e21.00176. doi: 10.5435/JAAOSGlobal-D-21-00176.
10
Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?
Front Oncol. 2021 Oct 15;11:710163. doi: 10.3389/fonc.2021.710163. eCollection 2021.
本文引用的文献
1
Osteonecrosis in children with acute lymphoblastic leukemia.
Haematologica. 2016 Nov;101(11):1295-1305. doi: 10.3324/haematol.2016.147595. Epub 2016 Oct 14.
2
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus.
Lancet Oncol. 2016 Jun;17(6):e231-e239. doi: 10.1016/S1470-2045(16)30035-3.
3
The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.
Haematologica. 2014 Nov;99(11):1716-21. doi: 10.3324/haematol.2014.109413. Epub 2014 Aug 22.
4
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.
Eur J Cancer. 2014 Oct;50(15):2685-94. doi: 10.1016/j.ejca.2014.06.023. Epub 2014 Jul 30.
5
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
Br J Haematol. 2014 Apr;165(1):126-33. doi: 10.1111/bjh.12733. Epub 2014 Jan 15.
6
Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.
Eur J Cancer. 2014 Jan;50(2):251-9. doi: 10.1016/j.ejca.2013.09.027. Epub 2013 Nov 11.
7
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.
Eur J Haematol. 2013 May;90(5):404-12. doi: 10.1111/ejh.12097. Epub 2013 Apr 2.
8
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
Lancet Oncol. 2012 Sep;13(9):906-15. doi: 10.1016/S1470-2045(12)70274-7. Epub 2012 Aug 15.
9
Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.
Clin Rev Allergy Immunol. 2011 Aug;41(1):102-13. doi: 10.1007/s12016-010-8217-z.
10
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
Blood. 2011 Feb 24;117(8):2340-7; quiz 2556. doi: 10.1182/blood-2010-10-311969. Epub 2010 Dec 10.
Zotero 插件